| Literature DB >> 32082424 |
Ana Denise Brandão1, Jeferson Hernandes da Silva1, Sarah Mariane Oliveira Lima1, Leiciane Lima1, Bhianca Loize1, Antônio Adolfo Mattos de Castro2, Claudia Kümpel1, Elias Ferreira Porto1.
Abstract
BACKGROUND: Metabolic syndrome (MS) is a complex disorder represented by a set of cardiovascular risk factors usually related to central fat deposition, insulin resistance, hypertension and dyslipidemia. It is associated with accelerated atherosclerosis in response to chronic inflammation and vascular endothelial dysfunction, increasing overall mortality. The objective to evaluate the short and long term effect of the comprehensive cardiac rehabilitation program and intensive lifestyle intervention in metabolic syndrome patients.Entities:
Keywords: Cardiac rehabilitation; Life style; Metabolic syndrome
Year: 2020 PMID: 32082424 PMCID: PMC7023691 DOI: 10.1186/s13098-020-0522-y
Source DB: PubMed Journal: Diabetol Metab Syndr ISSN: 1758-5996 Impact factor: 3.320
Fig. 1Study design
Demographic characteristics at baseline and after cardiac rehabilitation
| Pre-rehabilitation (%) (n = 47) | Post-rehabilitation (%) (n = 47) | p | Follow up (n = 28) | p | |
|---|---|---|---|---|---|
| Man (%) | 22.2 | 22.2 | 0.99 | 22.2 | 0.99 |
| Woman (%) | 77.8 | 77.8 | 0.98 | 77.8 | 0.98 |
| Age (years) | 61.6 ± 6.2 | 61.9 ± 6.2 | 0.54 | 62.6 ± 9.8 | 0.4 |
| Overweight | 22.2 | 33.3 | 33.3 | 0.99 | |
| Obesity degree I (%) | 44.4 | 38.8 | 44.4 | 0.055 | |
| Obesity degree II (%) | 22.2 | 11 | 5.5 | 0.058 | |
| Obesity degree III (%) | 5.5 | 11 | 0.41 | 16.6 | 0.42 |
| HBA1C < 6% | 33.3 | 22.2 | 0.48 | 16.6 | 0,44 |
| SBH controlled (%) | 11 | 33.3 | 33.3 | 0.99 | |
| Total cholesterol > 200 mg/dl (%) | 55.5 | 66.6 | 0.74 | 60 | 0.78 |
| HDL cholesterol | |||||
| Man < 40 mg/dl (%) | 75 | 50 | 25 | ||
| Woman < 50 mg/dl (%) | 64.2 | 71.4 | 0.65 | 71 | 0.99 |
| LDL > 135 mg/dl (%) | 77.7 | 83.3 | 0.87 | 90 | 0.78 |
| Triglycerides > 150 mg/dl (%) | 66.6 | 77.7 | 0.65 | 80 | 0.85 |
| Waist circumference | |||||
| Woman < 88 cm (%) | 0 | 0 | 25 | ||
| Man < 102 cm (%) | 0 | 25 | 25 | ||
The values highlighted in italics represent p < 0.05 pre-rehabilitation versus post-rehabilitation or post-rehabilitation versus follow up
HDL high density lipoprotein, LDL low density lipoprotein
Comparison of anthropometric results and physical capacity before and after intervention
| Pre-rehabilitation (%) (n = 47) | Post-rehabilitation (%) (n = 47) | p | Follow up (n = 28) | p | |
|---|---|---|---|---|---|
| BMI (kg/m2) | 32.6 ± 3.9 | 32.3 ± 4.7 | 0.41 | 32.4 ± 5.0 | 0.85 |
| Waist circumference (cm) | 108.8 ± 7.4 | 106.5 ± 8.5 | 0.2 | 106.1 ± 8.5 | 0.8 |
| Global fatigue (score) | 2.5 ± 1.3 | 0.66 ± 1.1 | 1.6 ± 1.0 | ||
| SMWT (m) | 474.1 ± 80.6 | 523.1 ± 71.8 | 499.6 ± 83.7 | 0.25 | |
| Bruce protocol (min) | 3.1 ± 1.2 | 4.1 ± 1.1 | 3.2 ± 1.1 | ||
| Systolic blood pressure (mmHg) | 141.2 ± 11.2 | 130.9 ± 13.9 | 124.5 ± 33.1 | 0.21 | |
| diastolic blood pressure (mmHg) | 86.7 ± 11.2 | 81.1 ± 9.1 | 0.064 | 72.7 ± 18.2 | 0.32 |
The values highlighted in italics represent p < 0.05 pre-rehabilitation versus post-rehabilitation or post-rehabilitation versus follow up
BMI body mass index, SMWT 6 min walking test, SD standard deviation
Values for total and fractionated cholesterol, triglycerides fasting glucose and glycosylated hemoglobin, before and after PRC
| Pre-rehabilitation (%) (n = 47) | Post-rehabilitation (%)(n = 47) | p | Follow up (n = 28) | p | |
|---|---|---|---|---|---|
| Fasting glucose (mg/dl) | 141.1 ± 68.7 | 123.1 ± 37.5 | 134.3 ± 58.2 | 0.27 | |
| HBA1C (mg/dl) | 7.0 ± 1.8 | 6.9 ± 1.4 | 0.42 | 7.6 ± 1.7 | 0.13 |
| Total cholesterol (mg/dl) | 209.7 ± 40.9 | 188.2 ± 35.8 | 193.8 ± 35.7 | 0.37 | |
| HDL cholesterol (mg/dl) | 46.5 ± 10.9 | 44.5 ± 10.8 | 0.29 | 40.1 ± 10.8 | 0.16 |
| LDL cholesterol (mg/dl) | 119.5 ± 35.9 | 108.3 ± 32.3 | 0.18 | 104.2 ± 31.5 | 0.38 |
| Triglycerides (mg/dl) | 209.5 ± 109 | 190.1 ± 65.3 | 190.3 ± 60.4 | 0.49 |
The values highlighted in italics represent p < 0.05 pre-rehabilitation versus post-rehabilitation or post-rehabilitation versus follow up
HBA1C A1c glycosylated hemoglobin, HDL high density lipoprotein, LDL low density lipoprotein
Absolute and relative frequencies to metabolic syndrome criteria, pre and post rehabilitation
| Variables | Pre-rehabilitation [n (%)] | Post-rehabilitation [n (%)] | Follow up [n (%)] |
|---|---|---|---|
| Five metabolic syndrome criteria | 11 (23.4) | 0 (0) | 5 (10.7) |
| Four metabolic syndrome criteria | 16 (34) | 10 (21.2) | 11 (39.2) |
| Tree metabolic syndrome criteria | 20 (42.5) | 19 (40) | 7 (25) |
| Two metabolic syndrome criteria | 0 (0) | 10 (21.2) | 5 (17.8) |
| One metabolic syndrome criteria | 0 (0) | 7 (14.8) | 0 (0) |
| Zero metabolic syndrome criteria | 0 (0) | 0 (0) | 0 (0) |
| Total | 47 (100) | 47 (100) | 28 (100) |
Effect size at short and long term of cardiac rehabilitation program for patients with metabolic syndrome
| Variables | Pre and post rehabilitation | Pre rehabilitation and follow up | ||||||
|---|---|---|---|---|---|---|---|---|
| d Conhen | CI 95% | TDE | Effect size | d Conhen | CI 95% | TDE | Effect size | |
| Fast glucose | 0.33 | 0.74 to 0.07 | 0.45 | Small effect | 0.05 | − 0.41 to 0.67 | 0.10 | No effect |
| Hb1AC | 0.11 | 0.29 to 0.51 | 0.53 | Small effect | − 0.33 | − 0.71 to 0.05 | 0.16 | Moderate effect |
| Total cholesterol | 0.52 | 0.10 to 0.90 | 0.64 | Moderate effect | 0.39 | 0.003 to 0.71 | 0.20 | Moderate effect |
| HDL cholesterol | 0.05 | 0.35 to 0.45 | 0.51 | No effect | − 0.54 | − 0.93 to − 0.14 | 0.28 | Moderate effect |
| LDL cholesterol | 0.5 | 0.08 to 0.91 | 0.63 | Moderate effect | 0.42 | 0.03 to 0.81 | 0.22 | Moderate effect |
| Triglycerides | 1.0 | 0.5 to 1.4 | 0.76 | Great effect | 0.54 | 0.14 to 0.95 | 0.13 | Moderate effect |
| Systolic blood pressure | 0.81 | 0.38 to 1.2 | 0.71 | Great effect | 0.51 | 0.1 to 0.9 | 0.32 | Moderate effect |
| Diastolic blood pressure | 0.61 | 0.17 to 1.1 | 0.66 | Moderate effect | 0.77 | 0.34 to 1.34 | 0.42 | Moderate effect |
HBA1C A1c glycosylated hemoglobin, HDL high density lipoprotein, LDL low density lipoprotein